Israel Englander Avadel Pharmaceuticals PLC Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$12.55 - $17.22 $20.2 Million - $27.7 Million	1,607,783 Added 786.07%	1,812,317 $30.6 Million
Q4 2023 Feb 14, 2024	BUY	$9.64 - $14.59 $1.97 Million - $2.98 Million	204,534 New	204,534 $2.89 Million
Q1 2023 May 15, 2023	SELL	$6.41 - $9.95 $2.05 Million - $3.19 Million	-320,426 Reduced 52.59%	288,910 $2.65 Million
Q4 2022 Feb 14, 2023	BUY	$5.02 - $10.0 $3.06 Million - $6.09 Million	609,336 New	609,336 $4.36 Million
Q2 2022 Aug 15, 2022	BUY	$1.07 - $6.95 $203,146 - $1.32 Million	189,857 Added 835.16%	212,590 $519,000
Q4 2021 Feb 14, 2022	BUY	$7.34 - $11.18 $166,860 - $254,154	22,733 New	22,733 $184,000
Q2 2021 Aug 16, 2021	SELL	$6.73 - $9.05 $217,903 - $293,020	-32,378 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$6.61 - $10.07 $1.87 Million - $2.85 Million	-282,973 Reduced 89.73%	32,378 $293,000
Q4 2020 Feb 16, 2021	SELL	$5.03 - $7.95 $1.34 Million - $2.11 Million	-265,775 Reduced 45.73%	315,351 $2.11 Million
Q3 2020 Nov 16, 2020	BUY	$5.02 - $8.98 $774,309 - $1.39 Million	154,245 Added 36.13%	581,126 $2.93 Million
Q2 2020 Aug 14, 2020	SELL	$7.25 - $11.75 $203,108 - $329,176	-28,015 Reduced 6.16%	426,881 $3.45 Million
Q1 2020 May 14, 2020	SELL	$4.06 - $10.64 $706,159 - $1.85 Million	-173,931 Reduced 27.66%	454,896 $3.61 Million
Q4 2019 Feb 14, 2020	BUY	$3.34 - $7.7 $1.7 Million - $3.93 Million	509,939 Added 428.92%	628,827 $4.75 Million
Q3 2019 Nov 14, 2019	BUY	$1.92 - $4.47 $228,264 - $531,429	118,888 New	118,888 $494,000
Q2 2019 Aug 14, 2019	SELL	$1.09 - $3.19 $70,553 - $206,482	-64,728 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$1.44 - $3.29 $12,085 - $27,612	-8,393 Reduced 11.48%	64,728 $93,000
Q4 2018 Feb 14, 2019	BUY	$1.74 - $4.66 $127,230 - $340,743	73,121 New	73,121 $189,000
Q3 2018 Nov 14, 2018	SELL	$4.08 - $7.14 $1.35 Million - $2.37 Million	-331,554 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$5.89 - $7.78 $2.21 Million - $2.92 Million	-375,225 Reduced 53.09%	331,554 $2.03 Million
Q1 2018 May 15, 2018	SELL	$6.76 - $11.7 $930,317 - $1.61 Million	-137,621 Reduced 16.3%	706,779 $5.15 Million
Q4 2017 Feb 14, 2018	BUY	$8.03 - $11.25 $1.43 Million - $2 Million	178,200 Added 26.75%	844,400 $6.92 Million
Q3 2017 Nov 14, 2017	BUY	$8.35 - $10.5 $5.56 Million - $7 Million	666,200	666,200 $7 Million

Others Institutions Holding AVDL

# of Institutions

Shares Held

1.07M

Call Options Held

Put Options Held

View Full List

About AVADEL PHARMACEUTICALS PLC

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $661M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

More about AVDL

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account